Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Urology|May 18, 2010
Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomyRobert S Svatek, Mark B Fisher, Michael B Williams, et al.
The Journal of Urology|December 21, 2010
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancerPeter C Black, Gordon A Brown, Colin P Dinney, et al.
BJU International|September 6, 2017
Effects of thiazolidinedione in patients with active bladder cancerRoger Li, Michael J Metcalfe, James E Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCCWassim Kassouf, Piyush K Agarwal, Harry W Herr, et al.
European Urology Open Science|July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival OutcomesWei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
BMJ Supportive & Palliative Care|September 24, 2018
Overall survival in older patients with cancerBeatrice J Edwards, Xiaotao Zhang, Ming Sun, et al.
The Journal of Urology|January 20, 2010
Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteriaRobert S Svatek, Mark B Fisher, Surena F Matin, et al.
Journal of Endourology|July 22, 2017
Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term OutcomesMichael Metcalfe, Gavin Wagenheim, Lianchun Xiao, et al.
Cancer|July 7, 2007
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experienceWassim Kassouf, Philippe E Spiess, Arlene Siefker-Radtke, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Urology|May 18, 2010
Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomyRobert S Svatek, Mark B Fisher, Michael B Williams, et al.
The Journal of Urology|December 21, 2010
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancerPeter C Black, Gordon A Brown, Colin P Dinney, et al.
BJU International|September 6, 2017
Effects of thiazolidinedione in patients with active bladder cancerRoger Li, Michael J Metcalfe, James E Ferguson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCCWassim Kassouf, Piyush K Agarwal, Harry W Herr, et al.
European Urology Open Science|July 13, 2023
Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival OutcomesWei Shen Tan, Valentina Grajales, Roberto Contieri, et al.
BMJ Supportive & Palliative Care|September 24, 2018
Overall survival in older patients with cancerBeatrice J Edwards, Xiaotao Zhang, Ming Sun, et al.
The Journal of Urology|January 20, 2010
Risk factor analysis in a contemporary cystectomy cohort using standardized reporting methodology and adverse event criteriaRobert S Svatek, Mark B Fisher, Surena F Matin, et al.
Journal of Endourology|July 22, 2017
Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term OutcomesMichael Metcalfe, Gavin Wagenheim, Lianchun Xiao, et al.
Cancer|July 7, 2007
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experienceWassim Kassouf, Philippe E Spiess, Arlene Siefker-Radtke, et al.
Pageof 21